Mowery et al., Next generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese mice, Molecular Metabolism 63 (2022) 101533
Seek medical advice if hiccups persist for more than 48 hours, significantly interfere with daily activities, or occur alongside severe abdominal pain, persistent vomiting, or difficulty swallowing
Retatrutide achieved its outcome 2024 weeks faster than either comparator's trial endpoint
Taken with a sensible diet and light to moderate exercise, GLP-1 Pro can be an effective tool to support healthy weight management
From a bulk purchasing perspective, tirzepatide is currently more readily available than retatrutide through both pharmaceutical and research channels, since tirzepatide already has FDA approval (as Mounjaro for type 2 diabetes and Zepbound for weight management)